Strasbourg, December 21, 2023 - 05:45 pm CET
TRANSGENE (Paris: TNG) today announces that Management will participate in several investor events in the upcoming investor events, as set out below.
Transgene will meet institutional investors at the 13th Annual LifeSci Advisors Corporate Access Event in San Francisco from January 8 to 10, 2024, in conjunction with the J.P. Morgan Healthcare conference.
The Company will also attend:
• 27th ODDO BHF Forum (virtual): January 15-16, 2024;
• Invest Securities Biomed Forum (Paris): January 30, 2024.
.../...
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer